Mexico Travel Vaccine Market to 2032
Overview
The Mexico Travel Vaccine Market is expected to reach a 974.27 USD Million by 2032 and is projected to grow at a CAGR of 11.49% from 2025 to 2032.
Revenue, 2024 (USD Million)
490.98
Forecast, 2032 (USD Million)
974.27
CAGR, 2024 - 2032
11.49%
Report Coverage
Mexico
Mexico Travel Vaccine Market 2018-2032 USD Million
Mexico Travel Vaccine Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 490.98 USD Million
- Projected Market Size (2032): 974.27 USD Million
- CAGR (2025-2032): 11.49%
Key Findings of Mexico Travel Vaccine Market
- The Mexico Travel Vaccine Market was valued at 974.27 USD Million in 2024.
- The Mexico Travel Vaccine Market is likely to grow at a CAGR of 11.49% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Injectable in Route of Administration Segment accounted for the largest share of the market with a revenue of 399.89 USD Million
- The fastest growing segment Typhoid in Disease Segment grew Fastest with a CAGR of 19.75% during the forecast period from 2024 to 2032.
Mexico Travel Vaccine Market Scope
Mexico Travel Vaccine Market Segmentation & Scope
Gender
- Female
- Male
Route of Administration
- Oral
- Injectable
Disease
- COVID-19
- Others
- Polio
- Malaria
- Tick-Borne Encephalitis
- Measles and Mumps
- DPT
- Rabies
- Yellow Fever
- Meningococcal Meningitis
- Japanese Encephalitis
- Influenza
- Varicella
- Cholera
- Hepatitis
- Typhoid
Patient Type
- Geriatric
- Pediatric
- Adult
Distribution Channel
- B2C
- B2B
Age Group
- Above 50 Years
- Less than 20 Years
- 20-50 Years
Type
- Viral Vector Vaccines
- DNA Vaccines
- Toxoid Vaccines
- Live-Attenuated Vaccines
- Subunit, Recombinant, Polysaccharide and Conjugate Vaccines
- Inactivated Vaccines
Category
- Required Vaccine
- Routine Vaccine
- Recommended Vaccine
Composition
- Mono Vaccines
- Combination Vaccines
Mexico Travel Vaccine Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2022 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 490.98 USD Million |
| Market Value in 2032 | 974.27 USD Million |
| CAGR (2025-2032) | 11.49% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Gender,Route of Administration,Disease,Patient Type,Distribution Channel,Age Group,Type,Category,Composition |
Regional Insights:
-
Leading Market (2024-2032): Mexico, leading in terms of revenue 490.98 USD Million in 2024
- Key Country: Mexico, leading in terms of revenue with value of 490.98 USD Million in 2024.
Segments and Scope
-
Mexico Travel Vaccine Market to 2032, By Gender
- Male is the largest segment in Mexico Travel Vaccine Market to 2032 with a revenue of 253.52 USD Million in the year 2024.
- Male is the Fastest growing segment in Mexico Travel Vaccine Market to 2032 with a Growth rate of 11.71 % in forecast period 2025-2032.
-
Mexico Travel Vaccine Market to 2032, By Route of Administration
- Injectable is the largest segment in Mexico Travel Vaccine Market to 2032 with a revenue of 399.89 USD Million in the year 2024.
- Injectable is the Fastest growing segment in Mexico Travel Vaccine Market to 2032 with a Growth rate of 11.64 % in forecast period 2025-2032.
-
Mexico Travel Vaccine Market to 2032, By Disease
- Typhoid is the largest segment in Mexico Travel Vaccine Market to 2032 with a revenue of 77.80 USD Million in the year 2024.
- Typhoid is the Fastest growing segment in Mexico Travel Vaccine Market to 2032 with a Growth rate of 19.75 % in forecast period 2025-2032.
-
Mexico Travel Vaccine Market to 2032, By Patient Type
- Adult is the largest segment in Mexico Travel Vaccine Market to 2032 with a revenue of 217.42 USD Million in the year 2024.
- Adult is the Fastest growing segment in Mexico Travel Vaccine Market to 2032 with a Growth rate of 12.15 % in forecast period 2025-2032.
-
Mexico Travel Vaccine Market to 2032, By Distribution Channel
- B2B is the largest segment in Mexico Travel Vaccine Market to 2032 with a revenue of 377.83 USD Million in the year 2024.
- B2B is the Fastest growing segment in Mexico Travel Vaccine Market to 2032 with a Growth rate of 11.65 % in forecast period 2025-2032.
-
Mexico Travel Vaccine Market to 2032, By Age Group
- 20-50 Years is the largest segment in Mexico Travel Vaccine Market to 2032 with a revenue of 239.76 USD Million in the year 2024.
- 20-50 Years is the Fastest growing segment in Mexico Travel Vaccine Market to 2032 with a Growth rate of 11.96 % in forecast period 2025-2032.
-
Mexico Travel Vaccine Market to 2032, By Type
- Inactivated Vaccines is the largest segment in Mexico Travel Vaccine Market to 2032 with a revenue of 132.47 USD Million in the year 2024.
- Inactivated Vaccines is the Fastest growing segment in Mexico Travel Vaccine Market to 2032 with a Growth rate of 12.67 % in forecast period 2025-2032.
-
Mexico Travel Vaccine Market to 2032, By Category
- Recommended Vaccine is the largest segment in Mexico Travel Vaccine Market to 2032 with a revenue of 224.50 USD Million in the year 2024.
- Recommended Vaccine is the Fastest growing segment in Mexico Travel Vaccine Market to 2032 with a Growth rate of 11.91 % in forecast period 2025-2032.
-
Mexico Travel Vaccine Market to 2032, By Composition
- Combination Vaccines is the largest segment in Mexico Travel Vaccine Market to 2032 with a revenue of 334.41 USD Million in the year 2024.
- Combination Vaccines is the Fastest growing segment in Mexico Travel Vaccine Market to 2032 with a Growth rate of 11.65 % in forecast period 2025-2032.
Mexico Travel Vaccine Market Company Share Analysis
| Company Name |
|
||
| Merck & Co., Inc. | |||
| Johnson & Johnson Services, Inc. | |||
| Pfizer Inc. | |||
| Sanofi | |||
| GSK plc. | |||
Mexico Travel Vaccine Market Geographical Sales Distribution, 2018-2032 USD Million
Mexico Travel Vaccine Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Mexico Travel Vaccine Market is segmented based on Segmentation Gender,Route of Administration,Disease,Patient Type,Distribution Channel,Age Group,Type,Category,Composition.
Mexico Travel Vaccine Market was valued at USD 490.98(Revenue in USD Million) in 2022.
Mexico Travel Vaccine Market is projected to grow at a CAGR of 11.49% during the forecast period of 2024 to 2032.
The Injectable segment is expected to dominate the Mexico Travel Vaccine Market, holding a largest market share of 399.89 USD Million in 2024
Mexico Travel Vaccine Market Scope
Mexico Travel Vaccine Market Segmentation & Scope
Gender
- Female
- Male
Route of Administration
- Oral
- Injectable
Disease
- COVID-19
- Others
- Polio
- Malaria
- Tick-Borne Encephalitis
- Measles and Mumps
- DPT
- Rabies
- Yellow Fever
- Meningococcal Meningitis
- Japanese Encephalitis
- Influenza
- Varicella
- Cholera
- Hepatitis
- Typhoid
Patient Type
- Geriatric
- Pediatric
- Adult
Distribution Channel
- B2C
- B2B
Age Group
- Above 50 Years
- Less than 20 Years
- 20-50 Years
Type
- Viral Vector Vaccines
- DNA Vaccines
- Toxoid Vaccines
- Live-Attenuated Vaccines
- Subunit, Recombinant, Polysaccharide and Conjugate Vaccines
- Inactivated Vaccines
Category
- Required Vaccine
- Routine Vaccine
- Recommended Vaccine
Composition
- Mono Vaccines
- Combination Vaccines
Frequently Asked Questions
The Mexico Travel Vaccine Market is segmented based on Segmentation Gender,Route of Administration,Disease,Patient Type,Distribution Channel,Age Group,Type,Category,Composition.
Mexico Travel Vaccine Market was valued at USD 490.98(Revenue in USD Million) in 2022.
Mexico Travel Vaccine Market is projected to grow at a CAGR of 11.49% during the forecast period of 2024 to 2032.
The estimated market value of the Mexico Travel Vaccine Market for final year is USD 974.27 (USD Million).
Mexico Travel Vaccine Market Company Profiling
Frequently Asked Questions
The Mexico Travel Vaccine Market is segmented based on Segmentation Gender,Route of Administration,Disease,Patient Type,Distribution Channel,Age Group,Type,Category,Composition.
Mexico Travel Vaccine Market was valued at USD 490.98(Revenue in USD Million) in 2022.
Mexico Travel Vaccine Market is projected to grow at a CAGR of 11.49% during the forecast period of 2024 to 2032.
The estimated market value of the Mexico Travel Vaccine Market for final year is USD 974.27 (USD Million).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.